Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02539615

A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old

A Single-arm, Multi-center Trial of the ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years of Age

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Atossa Therapeutics, Inc. · Industry
Sex
Female
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to measure the performance of the ForeCYTE Breast Aspirator for the collection and processing of Nipple Aspirate Fluid (NAF) specimens for cytology. Including collecting, processing and shipping samples, training staff, processing samples, sample interpretation and accurate and timely reporting in a manner resembling routine clinical use. The study will include a subset of patients who are known carriers of a BRCA germline mutation. NAF from this subset will be submitted for molecular testing in addition to cytology.

Conditions

Interventions

TypeNameDescription
DEVICEForeCYTE Breast Aspirator

Timeline

Start date
2015-09-01
Primary completion
2015-12-01
Completion
2016-03-01
First posted
2015-09-03
Last updated
2016-01-25

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT02539615. Inclusion in this directory is not an endorsement.